TM6SF2 is involved in very low-density lipoprotein (VLDL) secretion, and the rs58542926 variant has been associated with ALD cirrhosis [31], HCC [34], and NAFLD [36,37]. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.